PMI's Dividend Yield Expected to Range from 2.1% to 5%

Jan.05.2023

PMI's 2022 dividend yield is between 2.1% to 5%. It has a market value of 157 billion dollars and owns the IQOS brand.

Phimo International's (PMI) annual dividend yield for 2022 ranges from 2.1% to 5%.

Philip Morris International (PMI) has a market value of $157 billion, which is almost equivalent to the combined total market value of its two competitors. In addition to its leading cigarette brand, Marlboro, the company also owns the top-notch heat-not-burn brand, IQOS.

Since its launch in 2014, IQOS has amassed a customer base of 19.5 million. The growth in sales of IQOS has offset the decline in sales of cigarettes, which is why PMI's overall sales grew by 3.4% in the first nine months of 2022.

Screenshot of Phimo International's revenue-related data. Source: New York Stock Exchange.

Analysts at the New York Stock Exchange predict that the company's earnings will grow at a rate of 2.8% per year over the next five years. The dividend payout ratio for PMI is expected to reach around 92% by 2022.

At first glance, this seems to be in a favorable position. However, due to the minimal capital required for tobacco companies to operate, this allocation rate should be sustainable in the short term. As PMI's dividend growth rate is lower than its earnings in the coming years, dividends are expected to be very safe.

The most significant factor is that investors can purchase the shares of this tobacco giant at a reasonable valuation and receive a 5% dividend yield. The stock's forward P/E ratio of 18.7 is higher than the tobacco industry's average forward P/E ratio of 13.4.

Special Note: This article does not provide any investment references or suggestions.

#PMI

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement

In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.

Regulations

Dec.20 by 2Firsts Perspectives

Japan Tobacco launches third limited-edition Ploom AURA color “Aqua Green,” rolling out nationwide in December

Japan Tobacco (JT) announced that its heated tobacco device Ploom AURA will introduce a new limited-edition “Aqua Green” color in December. As the third release in JT’s 2025 limited series, the model will be available through official channels from December 1 and will roll out to convenience stores and selected tobacco retailers nationwide starting December 9.

Nov.24 by 2FIRSTS.ai

China’s Nov. Vape Exports to U.S. Hold at $549 Million, Sustaining High After October’s $591 Million Peak

China’s Nov. vape exports to the U.S. held at $549 million, following October’s $591 million record. 2025 YTD exports reached $3.72 billion, officially eclipsing 2024’s full-year total. This $1.14 billion 60-day surge signals a critical inventory overhang, heightening financial and regulatory risks for manufacturers.

Dec.22

Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List

The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.